The Indian Council of Medical Research (ICMR) has signed Memorandums of Agreement (MoAs) with both industry leaders and academic institutions. This strategic collaboration aims to advance the first-in-human Phase 1 clinical trials, a crucial step in the development of innovative treatments.
Union Minister Shri J P Nadda hailed the agreement as a landmark achievement in making cutting-edge treatments more affordable and accessible for every citizen. “This partnership is a crucial milestone in our journey towards ensuring that India achieves self-sufficiency in clinical development and enhances the growth of indigenous pharmaceutical innovations,” he stated.
More details awaited.
